CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.

Clinical trial NCT07538635 · RECRUITING

Trial details

NCT number: NCT07538635
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-risk R/R LBCL

Start date: 2026-04-20
Primary completion: 2028-02-29
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.